Tudóstér: Biofarmácia Tanszék publikációi

Feró, O., Varga, D., Nagy, É., Karányi, Z., Sipos, É., Engelhardt, J., Török, N., Balogh, I., Vető, B., Liko, I., Fóthi, Á., Szabó, Z., Halmos, G., Vécsei, L., Arányi, T., Székvölgyi, L.: DNA methylome, R-loop and clinical exome profiling of patients with sporadic amyotrophic lateral sclerosis.
Sci Data. 11 (1), 1-12, 2024.

Szabó, I., Biri-Kovács, B., Vári, B., Ranđelović, I., Vári-Mező, D., Juhász, É., Halmos, G., Bősze, S., Tóvári, J., Mező, G.: Targeting the Melanocortin 1 Receptor in Melanoma: biological Activity of alpha-MSH-Peptide Conjugates.
Int. J. Mol. Sci. 25 (2), 1-21, 2024.

Király, J., Szabó, E., Vass, A., Szegedi, K., Szenthe, K., Halmos, G., Szabó, Z.: A shikonin hatása az apoptózisban szerepet játszó miRNS-sek és azon targetjeinek expressziójára humán vesedaganatos sejtvonalakon.
In: Membrán-Transzport konferencia : programfüzet. Kiadta: a Pécsi Tudományegyetem, Pécsi Tudományegytem, Pécs, 82, 2023.

Csíkos, C., Képes, Z., Fekete, A., Vágner, A., Nagy, G., Gyuricza, B., Arató, V., Kárpáti, L., Mándity, I., Bruchertseifer, F., Halmos, G., Szikra, D., Trencsényi, G.: Evaluation of the therapeutic efficacy of 213Bi-labelled DOTA-conjugated alpha-melanocyte stimulating hormone peptide analogues in melanocortin-1 receptor positive preclinical melanoma model.
Int. J. Pharm. 644 1-9, 2023.

Trencsényi, G., Enyedi, K., Mező, G., Halmos, G., Képes, Z.: NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: a Preclinical Review.
Int. J. Mol. Sci. 24 (16), 1-34, 2023.

Szegedi, K., Szabó, Z., Kállai, J., Király, J., Szabó, E., Bereczky, Z., Juhász, É., Dezső, B., Szász, C., Zsebik, B., Flaskó, T., Halmos, G.: Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors.
J Clin Med. 12 (13), 1-18, 2023.

Trencsényi, G., Halmos, G., Képes, Z.: Radiolabeled NGR-Based Heterodimers for Angiogenesis Imaging: a Review of Preclinical Studies.
Cancers (Basel). 15 (18), 1-22, 2023.

Király, J., Szabó, E., Fodor, P., Fejes, Z., Nagy, B., Juhász, É., Vass, A., Choudhury, M., Kónya, G., Halmos, G., Szabó, Z.: Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways.
Molecules. 28 (18), 1-22, 2023.

Halmos, G., Szabó, Z., Juhász, É., Schally, A.: Signaling mechanism of growth hormone-releasing hormone receptor.
In: Hormone Receptors: Structures and Functions / Gerald Litwack, Academic Press Inc Elsevier Science, San Diego, 1-26, 2023, (Vitamins and Hormones, ISSN 0083-6729 ; 123.) ISBN: 9780443134555

Rebenku, I., Bartha, F., Katona, T., Zsebik, B., Antalffy, G., Takács, L., Molnár, B., Vereb, G.: Taking molecular pathology to the next level: whole slide multicolor confocal imaging with the Pannoramic Confocal digital pathology scanner.
Cytom. Part A. 103 (3), 198-207, 2023.

Vass, A., Szabó, Z., Király, J., Fodor, P., Steli, Á., Szabó, E., Szegedi, K., Halmos, G.: Transzporterek expressziójának vizsgálata humán vesekarcinómában.
In: Membrán-Transzport konferencia : programfüzet. Kiadta: a Pécsi Tudományegyetem, Pécsi Tudományegytem, Pécs, 121, 2023.

Steli, Á., Király, J., Szász, C., Vass, A., Szegedi, K., Szabó, Z., Halmos, G.: Újszerű biomarkerek vizsgálata vesetumorokban.
In: Membrán-Transzport konferencia : programfüzet. Kiadta: a Pécsi Tudományegyetem, Pécsi Tudományegytem, Pécs, 107, 2023.

Király, J., Fodor, P., Szenthe, K., Szabó, E., Flaskó, T., Szegedi, K., Zsebik, B., Szász, C., Halmos, G., Szabó, Z.: Angiogenezismarkerek és miRNS-ek kapcsolatának vizsgálata humán vesekarcinómában.
Magyar Onkol. 66 249-250, 2022.

Schuster, S., Juhász, É., Halmos, G., Neundorf, I., Gennari, C., Mező, G.: Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates.
Int. J. Mol. Sci. 23 (9), 1-18, 2022.

Fodor, P., Király, J., Szabó, Z., Halmos, G., Zsebik, B.: Effect of quercetin on metastatic uveal melanoma cell line.
In: Biotechnology at the University of Debrecen - 2022 International Symposium Abstract Book / Faculty of Science and Technology, Department of Molecular Biotechnology and Microbiology, Institute of Biotechnology and Faculty of Agricultural and Food Sciences and Enviromental Management, Central Laboratory of Agricultural and Food Products, Faculty of Science and Technology, Department of Molecular Biotechnology and Microbiology, Institute of Biotechnology and Faculty of Agricultural and Food Sciences and Enviromental Management, Central Laboratory of Agricultural and Food Products, Debrecen, 71, 2022. ISBN: 9789634904670

Szabó, Z., Juhász, É., Schally, A., Dezső, B., Huga, S., Hernádi, Z., Halmos, G., Kiss, C.: Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Primary Human Endometrial Carcinomas: novel Therapeutic Approaches.
Molecules. 27 (9), 1-13, 2022.

Kónya, G., Szabó, Z., Király, J., Dobos, N., Zsebik, B., Szegedi, K., Halmos, G.: Expression of Indoleamine 2,3-Dioxygenase (IDO) and Pten in Human Renal Carcinoma.
In: Biotechnology at the University of Debrecen - 2022 International Symposium Abstract Book / Faculty of Science and Technology, Department of Molecular Biotechnology and Microbiology, Institute of Biotechnology and Faculty of Agricultural and Food Sciences and Enviromental Management, Central Laboratory of Agricultural and Food Products, Faculty of Science and Technology, Department of Molecular Biotechnology and Microbiology, Institute of Biotechnology and Faculty of Agricultural and Food Sciences and Enviromental Management, Central Laboratory of Agricultural and Food Products, Debrecen, 75, 2022.

Szabó, Z., Király, J., Kónya, G., Szegedi, K., Halmos, G.: Expression of miRNAs and Angiogenesis Markers in Human Kidney Cancer.
In: Biotechnology at the University of Debrecen - 2022 International Symposium Abstract Book / Faculty of Science and Technology, Department of Molecular Biotechnology and Microbiology, Institute of Biotechnology and Faculty of Agricultural and Food Sciences and Enviromental Management, Central Laboratory of Agricultural and Food Products, Faculty of Science and Technology, Department of Molecular Biotechnology and Microbiology, Institute of Biotechnology and Faculty of Agricultural and Food Sciences and Enviromental Management, Central Laboratory of Agricultural and Food Products, Debrecen, 26, 2022.

Király, J., Fodor, P., Szenthe, K., Szabó, E., Flaskó, T., Szegedi, K., Zsebik, B., Szász, C., Halmos, G., Szabó, Z.: miRNS-ek és angiogenezis markerek kapcsolatának vizsgálata humán vese karcinómában.
In: Abstract book of the 6th International Cholnoky Symposium. Kiadta: a Pécsi Tudományegyetem, Pécsi Tudományegyetem, Pécs, 10, 2022.

Fodor, P., Király, J., Szabó, Z., Halmos, G., Zsebik, B.: Quercetin hatásának vizsgálata metasztatikus uveális melanóma sejtvonalon.
Magyar Onkol. 66 249, 2022.

Király, J., Szabó, E., Fodor, P., Zsebik, B., Kónya, G., Vass, A., Halmos, G., Szabó, Z.: Shikonin inhibits proliferation of human kidney cancer cells through induction of apoptosis.
In: Biotechnology at the University of Debrecen - 2022 International Symposium Abstract Book. Ed.: Faculty of Science and Technology, Department of Molecular Biotechnology and Microbiology, Institute of Biotechnology and Faculty of Agricultural and Food Sciences and Enviromental Management, Central Laboratory of Agricultural and Food Products, Faculty of Science and Technology, Department of Molecular Biotechnology and Microbiology, Institute of Biotechnology and Faculty of Agricultural and Food Sciences and Enviromental Management, Central Laboratory of Agricultural and Food Products, Debrecen, 74, 2022. ISBN: 9789634904670

Cai, R., Zhang, X., Wang, H., Cui, T., Halmos, G., Sha, W., He, J., Popovics, P., Vidaurre, I., Zhang, C., Mirsaeidi, M., Schally, A.: Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity.
Peptides. 150 1-13, 2022.

Fodor, P., Király, J., Szabó, Z., Halmos, G., Zsebik, B.: The potential applicability of quercetin in the treatment of uveal melanoma tumour metastases.
In: Abstract book of the 6th International Cholnoky Symposium. Kiadta: a Pécsi Tudományegyetem, Pécsi Tudományegyetem, Pécs, 25, 2022.

Papp, T., Ferenczi, Z., Szilágyi, B., Petró, M., Varga, A., Kókai, É., Berényi, E., Oláh, G., Halmos, G., Szűcs, P., Mészár, Z.: Ultrasound Used for Diagnostic Imaging Facilitates Dendritic Branching of Developing Neurons in the Mouse Cortex.
Front. Neurosci. 162022.

Fodor, P., Molnár-Fodor, K., Zsebik, B., Szabó, Z., Dobos, N., Schally, A., Halmos, G.: Angiogenezisgátló célzott terápiás VEGF-inhibitor és citotoxikus peptidhormon-analóg kombinált alkalmazásának vizsgálata uvealis melanomában in vitro.
Magyar Onkol. 65 (Suppl.), 19, 2021.

Kónya, G., Király, J., Dobos, N., Szegedi, K., Zsebik, B., Fodor, P., Szabó, Z., Halmos, G.: Az indolamin-2,3-dioxigenáz (IDO) és a PTEN expressziójának vizsgálata vesetumorokban és humán vesedaganat-sejtvonalakon.
Magyar Onkol. 65 (Suppl.1), 34, 2021.

Kónya, G., Szabó, Z., Király, J., Dobos, N., Zsebik, B., Szegedi, K., Halmos, G.: Expression of indoleamine 2,3-dioxygenase (IDO) and PTEN in human renal carcinoma.
In: Medical Conference for PhD Students and Experts of Clinical Sciences, Book of Abstracts / publ. by Doctoral Student Association of the University of Pécs, University of Pécs, Pécs, 103, 2021.

Szabó, Z., Dezső, B., Molnár-Fodor, K., Szegedi, K., Flaskó, T., Szabó, E., Oláh, G., Sipos, É., Dobos, N., Gardi, J., Schally, A., Halmos, G.: Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer.
Molecules. 26 (5), 1-14, 2021.

Király, J., Szabó, E., Fejes, Z., Nagy, B., Fodor, P., Kónya, G., Halmos, G., Szabó, Z.: Shikonin inhibits proliferation of human kidney cancer cells through induction of apoptosis.
In: Medical Conference for PhD Students and Experts of Clinical Sciences, Book of Abstracts / publ. by Doctoral Student Association of the University of Pécs, University of Pécs, Pécs, 102, 2021.

Harda, K., Halmos, G.: Amitől minden nő retteg: policisztás ovárium szindróma.
Gyógyszerészet. 64 (4), 214-218, 2020.

Molnár-Fodor, K., Sipos, É., Dobos, N., Nagy, J., Steiber, Z., Méhes, G., Dull, K., Székvölgyi, L., Schally, A., Halmos, G.: Correlation between the Expression of Angiogenic Factors and Stem Cell Markers in Human Uveal Melanoma.
Life (Basel). 10 (12), 1-15, 2020.

Molnár-Fodor, K., Dobos, N., Nagy, J., Méhes, G., Halmos, G.: Correlations between the Expression of Angiogenic Factors and Stem Cell Markers in Human Uveal Melanoma.
In: 4th National Conference of Young Biotechnologists : Abstract Book "FIBOK 2020" / publ. University of Debrecen, University of Debrecen, Debrecen, 56, 2020.

Király, J., Szabó, E., Fejes, Z., Nagy, B., Fodor, P., Szabó, Z., Halmos, G.: Effect of Shikonin on the Expression of Oncogenic miRNAs in Human Renal Cancer Cell Lines.
In: 4th National Conference of Young Biotechnologists : Abstract Book "FIBOK 2020" / publ. University of Debrecen, University of Debrecen, Debrecen, 58, 2020.

Harda, K., Szabó, Z., Juhász, É., Dezső, B., Kiss, C., Schally, A., Halmos, G.: Expression of Somatostatin Receptor Subtypes (SSTR-1-SSTR-5) in Pediatric Hematological and Oncological Disorders.
Molecules. 25 (23), 1-14, 2020.

Molnár-Fodor, K., Dobos, N., Schally, A., Steiber, Z., Halmos, G.: The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma.
In: 4th National Conference of Young Biotechnologists : Abstract Book "FIBOK 2020" / publ. University of Debrecen, University of Debrecen, Debrecen, 50, 2020.

Molnár-Fodor, K., Dobos, N., Schally, A., Steiber, Z., Oláh, G., Sipos, É., Székvölgyi, L., Halmos, G.: The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma.
Oncotarget. 11 (2), 175-187, 2020.

Szabó, E., Szabó, Z., Fejes, Z., Nagy, B., Harda, K., Szegedi, K., Halmos, G.: A shikonin humán vesedaganat-sejtvonalakra kifejtett apoptotikus hatása.
Magyar Onkol. 63 (Suppl1), 63, 2019.

Halász, L., Karányi, Z., Boros-Oláh, B., Kuik-Rózsa, T., Sipos, É., Nagy, É., Mosolygó, Á., Türk-Mázló, A., Rajnavölgyi, É., Halmos, G., Székvölgyi, L.: Corrigendum: RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases.
Genome Res. 29 (1), 157-157, 2019.

Boros-Oláh, B., Dobos, N., Hornyák, L., Szabó, Z., Karányi, Z., Halmos, G., Roszik, J., Székvölgyi, L.: Drugging the R-loop interactome: RNA-DNA hybrid binding proteins as targets for cancer therapy.
DNA Repair. 84 1-10, 2019.

Halmos, G., Dobos, N., Juhász, É., Szabó, Z., Schally, A.: Hypothalamic Releasing Hormones.
In: Hormonal signaling in biology and medicine : comprehensive modern endocrinology. Ed.: by Gerald Litwack, Academic Press, London, 43-68, 2019. ISBN: 9780128138144

Murányi, J., Varga, A., Gyulavári, P., Pénzes, K., Németh, C., Csala, M., Pethő, L., Csámpai, A., Halmos, G., Peták, I., Vályi-Nagy, I.: Novel Crizotinib-GnRH conjugates revealed the significance of lysosomal trapping in GnRH-based drug delivery systems.
Int. J. Mol. Sci. 20 (22), 1-23, 2019.

Pethő, L., Murányi, J., Pénzes, K., Gurbi, B., Brauswetter, D., Halmos, G., Csík, G., Mező, G.: Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers.
Int. J. Mol. Sci. 20 (20), 1-17, 2019.

Sipos, É., Dobos, N., Rózsa, D., Molnár-Fodor, K., Oláh, G., Szabó, Z., Székvölgyi, L., Schally, A., Halmos, G.: Characterization of Luteinizing hormone-releasing hormone (LH-RH-I) receptor type I as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.
OncoTargets Ther. 11 933-941, 2018.

Schuster, S., Biri-Kovács, B., Szeder, B., Buday, L., Gardi, J., Szabó, Z., Halmos, G., Mező, G.: Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification.
Pharmaceutics. 10 (4), 1-19, 2018.

Oláh, G., Dobos, N., Vámosi, G., Szabó, Z., Sipos, É., Molnár-Fodor, K., Harda, K., Schally, A., Halmos, G.: Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).
Eur. J. Pharm. Sci. 123 371-376, 2018.

Harda, K., Szabó, Z., Szabó, E., Oláh, G., Molnár-Fodor, K., Szász, C., Méhes, G., Schally, A., Halmos, G.: Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma.
Molecules. 23 (7), 1-13, 2018.

Schuster, S., Biri-Kovács, B., Szeder, B., Farkas, V., Buday, L., Szabó, Z., Halmos, G., Mező, G.: Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin-GnRH-III conjugates developed for targeted drug delivery.
Beilstein J. Org. Chem. 14 756-771, 2018.

Hornyák, L., Dobos, N., Koncz, G., Karányi, Z., Páll, D., Szabó, Z., Halmos, G., Székvölgyi, L.: The role of indoleamine-2,3-dioxygenase (IDO) in cancer development, diagnostics, and therapy.
Front. Immunol. 9 (151), 1-8, 2018.

Sipos, É., Dull, K., Treszl, A., Steiber, Z., Méhes, G., Dobos, N., Molnár-Fodor, K., Oláh, G., Székvölgyi, L., Schally, A., Halmos, G.: Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
Oncol. Rep. 37 1927-1934, 2017.

Halász, L., Karányi, Z., Boros-Oláh, B., Kuik-Rózsa, T., Sipos, É., Nagy, É., Mosolygó, Á., Türk-Mázló, A., Rajnavölgyi, É., Halmos, G., Székvölgyi, L.: RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases.
Genome Res. 27 1063-1073, 2017.

Zarándi, M., Cai, R., Kovács, M., Popovics, P., Szalontay, L., Cui, T., Sha, W., Jászberényi, M., Varga, J., XianYang, Z., Block, N., Rick, F., Halmos, G., Schally, A.: Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth.
Peptides. 89 60-70, 2017.

Szegedi, K., Szabó, Z., Flaskó, T., Halmos, G.: A mikroRNS-ek jelenléte vesetumorokban és lehetséges diagnosztikai-prognosztikai szerepük.
Magyar Urol. 18 (4), 183-188, 2016.

Szabó, Z., Szegedi, K., Gombos, K., Mahua, C., Flaskó, T., Harda, K., Halmos, G.: Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC.
Urol. Oncol.-Semin. Orig. Investig. 34 (12), 533, 2016.

Harda, K.: Nem megfelelően kihasznált lehetőségek: a probiotikumok hazai eladási tendenciái.
Gyógyszertár. 15 (9), 4-5, 2016.

Szabó, I., Bősze, S., Orbán, E., Sipos, É., Halmos, G., Kovács, M., Mező, G.: Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.
J. Pept. Sci. 21 (5), 426-435, 2015.

Halmos, G., Bácskay, I., Harda, K.: Gyógyszerészi gondozási példák.
Debreceni Egyetem, Debrecen, 120 p., 2015.

Harda, K.: Öntsünk tiszta probiotikumot a pohárba!.
Gyógyszertár. 14 (4), 10-12, 2015.

Halmos, G., Bácskay, I., Harda, K.: Pharmaceutical Care Practical Study Notes.
Debreceni Egyetem, Debrecen, 129 p., 2015.

Halmos, G.: Selected chapters of pharmaceutical bioanalytical methods.
Debreceni Egyetem, Debrecen, 126 p., 2015.

Halmos, G.: Válogatott fejezetek a gyógyszerészi bioanalitikából.
Debreceni Egyetem, Debrecen, 137 p., 2015.

Dobos, N.: Neuroinflammation in depression.
University of Griningen, Groningen, 131 p., 2014. ISBN: 9789036769341

Mezey, G., Treszl, A., Schally, A., Block, N., Vízkeleti, L., Juhász, A., Klekner, Á., Nagy, J., Balázs, M., Halmos, G., Bognár, L.: Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.
J. Cancer Res. Clin. Oncol. 140 (10), 1641-1649, 2014.

Molnár-Fodor, K.: Az AN-152 (AEZS-108) célzott daganatterápiás készítmény hatásmechanizmusának vizsgálata.
In: "A mi tendenciáink..." Szakkollégiumi Tanulmányok, 2. : Hatvani István Szakkollégium Debreceni Egyetem Tudományegyetemi Karok. Szerk.: Dorogi Zoltán, Uri Dénes Mihály, Debreceni Egyetem Tudományegyetemi Karok Hatvani István Szakkollégiuma, Debrecen, 161-168, 2013, 2063-6059

Oláh, G., Steiber, Z., Halmos, G.: Iránytű műkönnyekhez: gyógyszerészeknek.
Gyógyszerészet. 57 (2), 77-80, 2013.

Szepesházi, K., Schally, A., Block, N., Halmos, G., Nadji, M., Szalontay, L., Vidaurre, I., Abi-Chaker, A., Rick, F.: Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108.
Oncotarget. 4 (5), 751-760, 2013.

Rick, F., Abi-Chaker, A., Szalontay, L., Perez, R., Jászberényi, M., Jayakumar, A., Shamaladevi, N., Szepesházi, K., Vidaurre, I., Halmos, G., Krishan, A., Block, N., Schally, A.: Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.
Proc. Natl. Acad. Sci. U.S.A. 110 (7), 2617-2622, 2013.

Treszl, A., Steiber, Z., Schally, A., Block, N., Dezső, B., Oláh, G., Rózsa, B., Molnár-Fodor, K., Buglyó, A., Gardi, J., Berta, A., Halmos, G.: Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma.
Oncotarget. 4 (10), 1721-1728, 2013.

Cai, R., Schally, A., Cui, T., Szalontay, L., Halmos, G., Sha, W., Kovács, M., Jászberényi, M., He, J., Rick, F., Popovics, P., Kanashiro-Takeuchi, R., Hare, J., Block, N., Zarándi, M.: Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.
Peptides. 52C 104-112, 2013.

Seitz, S., Buchholz, S., Schally, A., Jayakumar, A., Weber, F., Papadia, A., Rick, F., Szalontay, L., Treszl, A., Köster, F., Ortmann, O., Hohla, F.: Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].
Anti-Cancer Drugs. 24 (2), 150-157, 2013.

Hegedűs, R., Manea, M., Orbán, E., Szabó, I., Kiss, É., Sipos, É., Halmos, G., Mező, G.: Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates.
Eur. J. Med. Chem. 56 155-165, 2012.

Stangelberger, A., Schally, A., Rick, F., Varga, J., Baker, B., Zarándi, M., Halmos, G.: Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins.
Prostate. 72 (5), 555-565, 2012.

Oláh, G., Steiber, Z., Halmos, G.: Mi folyik a műkönnyekkel?.
Gyógyszerészet. 56 (11), 663-666, 2012.

Klukovits, A., Schally, A., Szalontay, L., Vidaurre, I., Papadia, A., Zarándi, M., Varga, J., Block, N., Halmos, G.: Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers.
Cancer. 118 (3), 670-680, 2012.

Szepesházi, K., Schally, A., Rick, F., Block, N., Vidaurre, I., Halmos, G., Szalontay, L.: Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-II.
Anti-Cancer Drugs. 23 (9), 906-913, 2012.

Szepesházi, K., Schally, A., Keller, G., Block, N., Benten, D., Halmos, G., Szalontay, L., Vidaurre, I., Jászberényi, M., Rick, F.: Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 [AEZS- 108].
Oncotarget. 3 (7), 686-699, 2012.

Schally, A., Halmos, G.: Targeting to Peptide Receptors.
In: Drug Delivery in Oncology : From Basic Research to Cancer Therapy (Vol.3). Szerk.: Kratz Felix, Senter Peter, Steinhagen Henning, Wiley-VCH, Weinheim, 1219-1262, 2012. ISBN: 9783527328239

Aigner, Z., Bácskay, I., Blazsó, G., Botz, L., Dévay, A., Doró, P., Dredán, J., Fehér, P., Fenyvesi, F., Gáspár, R., Gunda, T., Hajdú, Z., Halmos, G., Herczegh, P., Hohmann, J., Lázár, L., Liktor-Busa, E., Nagymajtényi, L., Pál, S., Pálfi, M., Perjési, P., Soós, G., Szökő, É., Takács-Novák, K., Tábi, T., Tósaki, Á., Tóthfalusi, L., Zelkó, R., Zupkó, I., Váradi, J., Veres, K.: Általános gyógyszerészeti ismeretek.
Medicina Könyvkiadó Zrt., Budapest, 496 p., 2011. ISBN: 9789632429441

Mező, G., Szabó, I., Kertész, I., Hegedűs, R., Orbán, E., Leurs, U., Bősze, S., Halmos, G., Manea, M.: Efficient synthesis of an (aminooxy) acetylated-somatostatin derivative using (aminooxy)acetic acid as a 'carbonyl capture' reagent.
J. Pept. Sci. 17 (1), 39-46, 2011.

Kiss, C., Molnár, A., Treszl, A., Szegedi, I., Klekner, Á., Bognár, L., Dezső, B., Halmos, G.: Expression of receptors for luteinizing hormone-releasing hormone in pediatric neurogenic tumors.
Pediatr. Blood Cancer. 57 (5), 783, 2011.

Szilasi, M., Buglyó, A., Treszl, A., Kiss, L., Schally, A., Halmos, G.: Gene expression of vasoactive intestinal peptide receptors in human lung cancer.
Int. J. Oncol. 39 (4), 1019-1024, 2011.

Papadia, A., Schally, A., Halmos, G., Varga, J., Seitz, S., Buchholz, S., Rick, F., Zarándi, M., Bellyei, S., Treszl, A., Szalontay, L., Lucci, I.: Growth Hormone-Releasing Hormone Antagonists Inhibit Growth of Human Ovarian Cancer.
Horm. Metab. Res. 43 (11), 816-820, 2011.

Rick, F., Schally, A., Block, N., Halmos, G., Perez, R., Fernandez, J., Vidaurre, I., Szalontay, L.: LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.
Prostate. 71 (7), 736-747, 2011.

Rózsa, B., Nadji, M., Schally, A., Dezső, B., Flaskó, T., Tóth, G., Mile, M., Block, N., Halmos, G.: Receptors for Luteinizing Hormone-Releasing Hormone (LHRH) in Benign Prostatic Hyperplasia (BPH) as Potential Molecular Targets for Therapy with LHRH Antagonist Cetrorelix.
Prostate. 71 (5), 445-452, 2011.

Steiber, Z., Treszl, A., Rózsa, B., Berta, A., Halmos, G.: Receptors for luteinizing hormone-releasing hormone (LH-RH) in human uveal melanoma as potential molecular targets for cancer therapy.
Acta Ophthalmol. 88 S246, 2011.

Barok, M., Balázs, M., Lázár, V., Rákosy, Z., Tóth, E., Treszl, A., Vereb, G., Colbern, G., Park, J., Szöllősi, J.: Characterization of a novel, trastuzumab resistant human breast cancer cell line.
Front. Biosci. (Elite Ed). 1 (2), 627-640, 2010.

Szabó, Z., Borbély, Á., Kardos, G., Somogyvári, F., Kemény-Beke, Á., Asztalos, L., Rozgonyi, F., Majoros, L.: In vitro efficacy of amphotericin B, 5-fluorocytosine, fluconazole, voriconazole and posaconazole against Candida dubliniensis isolates using time-kill methodology.
Mycoses. 53 (3), 196-199, 2010.

Molnár, A., Szegedi, I., Rózsa, B., Mile, M., Halmos, G., Kiss, C.: Peptidhormon-receptorok kifejeződése lymphoma és leukemia sejtvonalakon, valamint gyermekkori lymphomás esetekben.
Hematol. Transzfuziol. 43 43, 2010.

Hohla, F., Buchholz, S., Schally, A., Krishan, A., Rick, F., Szalontay, L., Papadia, A., Halmos, G., Koster, F., Aigner, E., Datz, C., Seitz, S.: Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.
Cancer Lett. 294 (1), 35-42, 2010.

Pozsgai, E., Schally, A., Halmos, G., Rick, F., Bellyei, S.: The inhibitory effect of a novel cytotoxic somatostatin analogue AN-162 on experimental glioblastoma.
Horm. Metab. Res. 42 (11), 781-786, 2010.

Rózsa, B., Juhász, A., Treszl, A., Tóth, G., Flaskó, T., Dezső, B., Block, N., Schally, A., Halmos, G.: Expression of mRNA for human type-I LHRH receptor transcript forms in human benign prostatic hyperplasia.
Int. J. Oncol. 35 (5), 1053-1059, 2009.

Ziegler, C., Brown, J., Schally, A., Erler, A., Gebauer, L., Treszl, A., Young, L., Fishman, L., Engel, J., Willenberg, H., Petersenn, S., Eisenhofer, G., Ehrhart-Bornstein, M., Bornstein, S.: Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: Antiproliferative effects of peptide analogues.
Proc. Natl. Acad. Sci. U.S.A. 106 (37), 15879-15884, 2009.

Molnár, A., Rózsa, B., Mile, M., Szegedi, I., Kiss, C., Halmos, G.: Expression of somatostatin receptors in childhood tumors and other malignancies.
Acta Physiol. Hung. 96 (1), 106-107, 2009.

Márka, M., Semjéni, M., Treszl, A., Tóth, G., Flaskó, T., Dezső, B., Halmos, G.: Expression of somatostatin receptor subtypes in human bladder carcinoma.
Acta Physiol. Hung. 96 (1), 100, 2009.

Mile, M., Juhász, B., Juhász, A., Dezső, B., Lukács, G., Halmos, G.: Expression of splice variants of luteinizing hormone-releasing hormone receptors in human colorectal cancers.
Acta Physiol. Hung. 96 (1), 105-106, 2009.

Hohla, F., Buchholz, S., Schally, A., Seitz, S., Rick, F., Szalontay, L., Varga, J., Zarándi, M., Halmos, G., Vidaurre, I., Krishan, A., Kurtoglu, M., Chandna, S., Aigner, E., Datz, C.: GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells.
Cell Cycle. 8 (19), 3149-3156, 2009.

Treszl, A., Schally, A., Seitz, S., Szalontay, L., Rick, F., Szepesházi, K., Halmos, G.: Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162.
Peptides. 30 (9), 1643-1650, 2009.

Halmos, G., Schally, A.: Peptide hormone receptors as new molecular targets in oncology.
Acta Physiol. Hung. 96 (1), 79-80, 2009.

Seitz, S., Schally, A., Treszl, A., Papadia, A., Rick, F., Szalontay, L., Szepesházi, K., Ortmann, O., Halmos, G., Hohla, F., Buchholz, S.: Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition.
Anticancer Drugs. 20 (7), 553-558, 2009.

Kertész, I., Pótári, N., Jószai, I., Semjéni, M., Rózsa, B., Galuska, L., Halmos, G.: The development of an 18F-labeled luteinising hormone-releasing hormone receptor targeting peptide ligand series.
Acta Physiol. Hung. 96 (1), 90-91, 2009.

Heinrich, E., Schally, A., Buchholz, S., Rick, F., Halmos, G., Mile, M., Groot, K., Hohla, F., Zarándi, M., Varga, J.: Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
Prostate. 68 (16), 1763-1772, 2008.

Papadia, A., Schally, A., Seitz, S., Buchholz, S., Treszl, A., Szalontay, L., Halmos, G., Lucci, I.: Experimental therapy of ES-2 human platinum resistant ovarian cancer with targeted cytotoxic somatostatin and LHRH analogues.
Gynecol. Oncol. 111 (2), 376, 2008.

Seitz, S., Schally, A., Papadia, A., Ortmann, O., Buchholz, S., Treszl, A.: Inhibition of tumor growth of MDA-MB-231 human breast cancers by targeted cytotoxic analogue of somatostatin AN-162 (AEZS-124).
Geburtshilfe Frauenheilkd. 68 S27, 2008.

Juergen, E., Rózsa, B., Schally, A., Dezső, B., Tóth, G., Flaskó, T., Block, N., Nadji, M., Halmos, G.: Luteinizing Hormone-Releasing Hormone (LHRH) receptors in BPH as potential molecular targets for therapy with Cetrorelix.
J. Urol. 179 (4), 449-450, 2008.

Szepesházi, K., Schally, A., Treszl, A., Seitz, S., Halmos, G.: Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
Anticancer Drugs. 19 (4), 349-358, 2008.

Barok, M., Balázs, M., Nagy, P., Rákosy, Z., Treszl, A., Tóth, E., Juhász, I., Park, J., Isola, J., Vereb, G., Szöllősi, J.: Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor.
Cancer Lett. 260 (1-2), 198-208, 2008.

Mile, M., Huga, S., Juhász, A., Treszl, A., Hernádi, Z., Halmos, G.: Bombesin/gastrin-releasing peptid receptorok mint molekuláris célpontok az endometriumkarcinóma kezelésében.
Magyar Onkol. 51 (4), 364, 2007.

Hohla, F., Schally, A., Kanashiro, C., Buchholz, S., Baker, B., Kannadka, C., Moder, A., Aigner, E., Datz, C., Halmos, G.: Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.
Proc. Natl. Acad. Sci. U.S.A. 104 (47), 18671-18676, 2007.

Szepesházi, K., Schally, A., Halmos, G.: LH-RH receptors in human colorectal cancers: unexpected molecular targets for experimental therapy.
Int. J. Oncol. 30 (6), 1485-1492, 2007.

Buchholz, S., Schally, A., Engel, J., Hohla, F., Heinrich, E., Koester, F., Varga, J., Halmos, G.: Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.
Proc. Natl. Acad. Sci. U.S.A. 104 1943-1946, 2007.

Semjéni, M., Treszl, A., Huga, S., Juhász, A., Hernádi, Z., Halmos, G.: Szomatosztatin receptorok expressziójan és ezek jelentősége a humán endometriumkarcinóma célzott terápiájában.
Magyar Onkol. 51 (4), 394, 2007.

Stangelberger, A., Schally, A., Zarándi, M., Heinrich, E., Groot, K., Havt, A., Kanashiro, C., Varga, J., Halmos, G.: The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers.
Prostate. 67 (12), 1339-1353, 2007.

Halmos, G., Schally, A., Bernardino, A., Varga, J.: Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas.
Int. J. Oncol. 29 (2), 463-469, 2006.

Treszl, A., Ladányi, A., Rákosy, Z., Buczkó, Z., Ádány, R., Balázs, M.: Molecular cytogenetic characterization of a novel cell line established from a superficial spreading melanoma.
Front. Biosci. 11 (1), 1844-1853, 2006.

Toida, M., Balázs, M., Rákosy, Z., Kató, K., Yamazaki, Y., Matsui, T., Suwa, T., Hatakeyama, D., Makita, H., Mori, S., Yamashita, T., Shibata, T., Ádány, R., Treszl, A.: Analysis of Ameloblastomas by Comparative Genomic Hybridization and Fluorescence in situ Hybridization.
Cancer Genet. Cytogenet. 159 (2), 99-104, 2005.

Juhász, A., Balázs, M., Sziklai, I., Rákosy, Z., Répássy, G., Ádány, R., Treszl, A.: Chromosomal imbalances in laryngeal and hypopharyngeal cancers detected by comparative genomic hybridization.
Cytometry A. 67 (2), 151-160, 2005.

Papadia, A., Schally, A., Seitz, S., Buchholz, S., Rick, F., Szalontay, L., Halmos, G., Treszl, A., Lucci, I.: Experimental therapy of ES-2 human platinum resistant ovarian cancer with growth hormone-releasing hormone antagonist JMR-132 or with targeted cytotoxic analog somatostatin AN-162.
Gynecol. Oncol. 112 (2), S128-S129, 2004.

Treszl, A., Ádány, R., Rákosy, Z., Kardos, L., Bégány, Á., Gilde, K., Balázs, M.: Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation.
Cytometry B. Clin. Cytom. 60B (1), 37-46, 2004.

Balázs, M., Rákosy, Z., Bégány, Á., Ádány, R., Treszl, A.: Interphase cytogenetic analysis shows frequent hemizygous and homozygous deletion of p16/MTS1/CDKN2A tumorsuppressor gene in sporadic primary melanomas.
Cytom. Part A. 59A (1), 69, 2004.

Kovács, J., Julesz, J., Mogyoróssy, M., Deli, M., Abrahám, C., Vecsernyés, M.: Asphyxia-induced release of alpha-melanocyte-stimulating hormone in newborn pigs.
Peptides. 22 (7), 1049-1053, 2001.

Bodnár, I., Göőz, P., Okamura, H., Tóth, E., Vecsernyés, M., Halász, B., Nagy, G.: Effect of neonatal treatment with monosodium glutamate on dopaminergic and L-DOPA-ergic neurons of the medial basal hypothalamus and on prolactin and MSH secretion of rats.
Brain Res. Bull. 55 (6), 767-774, 2001.

Schally, A., Halmos, G., Rékási, Z., Arencibia-Jimenez, J.: The actions of Luteinizing hormone-releasing hormone agonists, antagonosts, and cytotoxic analogues on the luteinizing hormone-releasing hormone receptors on the pituitary and tumors.
In: Infertility and Reproductive Medicine. Ed.: Paul Devroey, W. B. Saunders Company, USA, 17-44, 2001.

Vecsernyés, M., Nagy, G., Mészáros, L., Bodnár, L., Ahmed, K., Tóth, R., Julesz, J., Nagy, G.: Suckling-induced change in oxytocin but not in alpha-MSH concentrations of the median eminence, the neural-, intermediate- and anterior lobes of the pituitary gland.
Endocr. Res. 26 (3), 333-345, 2000.

Horváth, K., Somogyvári-Vigh, A., Kandár, Z., Vecsernyés, M., Arimura, A., Nagy, G.: Suckling-induced increase in cyclic AMP exclusively in the central region of the rat adenohypophysis.
Brain Res. 873 (1), 140-144, 2000.